The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2021
DOI: 10.22354/in.v25i3.942
|View full text |Cite
|
Sign up to set email alerts
|

Verificación del desempeño de la prueba rápida "AMP Rapid Test SARS-CoV-2 IgG/IgM- Cassettes"

Abstract: Objetivo: Verificación del desempeño de las pruebas serológicas rápidas utilizadas en el departamento de Risaralda, Colombia. Métodos: Estudio analitico, de corte transversal. Incluyó muestras de sueros de trabajadores de la salud de la ciudad de Pereira, quienes tuvieron sospecha clínica y epidemiológica por SARS-CoV-2. El procesamiento y validación de las pruebas fue realizado en las instalaciones de la Universidad Tecnológica de Pereira. Se calculó sensibilidad y especificidad de las pruebas rápidas serológ… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 34 publications
(82 reference statements)
0
1
0
Order By: Relevance
“…[ 7 ] Commercial ICG tests from leading brands are adequate for a methodology of rapid identification of individual SARS‐CoV‐2 infection even though asymptomatic, with sensitivity of 65–99% and specificity of 92–100% for IgM and IgG, respectively. [ 12 ] Since these tests present variable quality, studies indicate some results do not correlate with RT‐PCR in the acute phase of the infection, especially when tested between 8 and 11 days after the onset of symptoms [ 10 , 13 , 14 , 15 ] ; nevertheless, they are widely used in order to identify late phase IgG antibodies in individual exposed to SARS‐CoV‐2. False‐negative results with RT‐PCR may occur due to viral evolution.…”
Section: Introductionmentioning
confidence: 99%
“…[ 7 ] Commercial ICG tests from leading brands are adequate for a methodology of rapid identification of individual SARS‐CoV‐2 infection even though asymptomatic, with sensitivity of 65–99% and specificity of 92–100% for IgM and IgG, respectively. [ 12 ] Since these tests present variable quality, studies indicate some results do not correlate with RT‐PCR in the acute phase of the infection, especially when tested between 8 and 11 days after the onset of symptoms [ 10 , 13 , 14 , 15 ] ; nevertheless, they are widely used in order to identify late phase IgG antibodies in individual exposed to SARS‐CoV‐2. False‐negative results with RT‐PCR may occur due to viral evolution.…”
Section: Introductionmentioning
confidence: 99%